valerylsalicylate has been researched along with nitroarginine in 1 studies
Studies (valerylsalicylate) | Trials (valerylsalicylate) | Recent Studies (post-2010) (valerylsalicylate) | Studies (nitroarginine) | Trials (nitroarginine) | Recent Studies (post-2010) (nitroarginine) |
---|---|---|---|---|---|
24 | 0 | 5 | 3,935 | 11 | 175 |
Protein | Taxonomy | valerylsalicylate (IC50) | nitroarginine (IC50) |
---|---|---|---|
Nitric oxide synthase, endothelial | Bos taurus (cattle) | 1.2 | |
Nitric oxide synthase, endothelial | Homo sapiens (human) | 0.38 | |
Nitric oxide synthase, brain | Homo sapiens (human) | 1.265 | |
Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 4.12 | |
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.5 | |
Nitric oxide synthase, inducible | Homo sapiens (human) | 6.2 | |
Nitric oxide synthase, brain | Mus musculus (house mouse) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bratz, IN; Kanagy, NL | 1 |
1 other study(ies) available for valerylsalicylate and nitroarginine
Article | Year |
---|---|
Nitric oxide synthase-inhibition hypertension is associated with altered endothelial cyclooxygenase function.
Topics: Adrenergic alpha-Agonists; Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Isoenzymes; Male; Membrane Proteins; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitroarginine; Nitrobenzenes; Norepinephrine; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Salicylates; Sulfonamides; Vasoconstriction | 2004 |